LILRB4 Antibodies
Target Information
Receptor for class I MHC antigens. Recognizes a broad spectrum of HLA-A, HLA-B, HLA-C and HLA-G alleles. Involved in the down-regulation of the immune response and the development of tolerance, e.g. towards transplants. Interferes with TNFRSF5-signaling and NF-kappa-B up-regulation. Inhibits receptor-mediated phosphorylation of cellular proteins and mobilization of intracellular calcium ions. Detected in monocytes, macrophages, dendritic cells, lung, natural killer cells and B-cells. 3 alternatively spliced human isoforms have been reported. Note: This description may include information from UniProtKB.
Alternate Names
CD85 antigen-like family member K; CD85K; HM18; ILT-3; ILT3; Immunoglobulin-like transcript 3; leucocyte Ig-like receptor B4; leukocyte immunoglobulin like receptor B4; Leukocyte immunoglobulin-like receptor 5; Leukocyte immunoglobulin-like receptor subfamily B member 4; leukocyte immunoglobulin-like receptor subfamily B member 4 soluble isoform; leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4; leukocyte immunoglobulin-like receptor, subfamily B, member 4; LILRB4; LILRB5; LIR-5; LIR5; LIRB4; Monocyte inhibitory receptor HM18LILRB4 Antibody Products
3 ProductsWhy CST
Cell Signaling Technology is trusted by the global scientific research community. Our highly cited antibodies offer unrivaled specificity and reproducibility. Learn more about why researchers choose CST:
Contact
Don’t see an antibody for your specific needs? Browse more products, learn more about our services or get in touch with us: